Download
Download by
Scanning QR Code
Download app
Download app
Company Overview More
Aikang Medical Holdings Co., Ltd. is a company mainly engaged in the design, development, production and sale of orthopedic implants. The company commercializes and applies 3D printing technology to bone, joint and spine replacement implants, with a particular focus on hip and knee replacement implants. The 3D precision construction technology solutions developed by the company help surgeons simulate and plan operations, simplify the operation process, provide personalized surgical instruments and selected implants before surgery, and significantly improve the rehabilitation progress of patients. The company mainly sells products in the domestic market and overseas markets such as the UK.
CEO: Zhijiang Li
Market: Hong Kong motherboard
Futu Hot List
HKUSCN
Trade HeatSearch HeatNews Heat
SymbolLatest price%Chg

Loading...

Watchlist
Futubull > Quotes > 01789 Ak Medical > Key Indicators
01789 Ak Medical
6.030-0.230-3.67%
YOY
Do not show
Hide blank lines
(Q6)2021/06/30(FY)2020/12/31(Q6)2020/06/30(FY)2019/12/31
Per Share IndicaTor
Operating Cash Flow Per Share
-96.47% 0.0051 42.51% 0.2186 35.84% 0.1434 9.01% 0.1534
Cash Flow Per Share
-173.25% -0.1795 410.89% 0.4906 456.26% 0.245 -43.91% -0.1578
Operating Income Per Share
2.45% 0.4823 12.22% 1.1028 -1.28% 0.4707 48.83% 0.9827
Net Asset Per Share
19.46% 2.259 83.85% 2.1758 81.98% 1.8909 27.88% 1.1835
Basic Earning Per Share
-26.83% 0.12 14.83% 0.333 20.59% 0.164 81.25% 0.29
Diluted  Earning Per Share
-26.83% 0.12 19.35% 0.333 20.59% 0.164 74.38% 0.279
Profitability
Gross Profit Ratio
-1.9% 68.881% -0.58% 69.011% 0.93% 70.217% 1.95% 69.413%
Operating Profit Ratio
-28.29% 28.800% 4.65% 35.632% 14.9% 40.160% 19.42% 34.048%
Net Profit Ratio
-26.76% 24.905% 5.26% 30.328% 14.9% 34.004% 19.38% 28.811%
Earning Before Tax Ratio
-28.47% 29.402% 4.88% 36.374% 15.01% 41.102% 19.36% 34.682%
ROE
-49.08% 5.417% -24.72% 20.315% -26.04% 10.638% 43.69% 26.988%
ROA
-46.7% 4.393% -21.92% 16.023% -24.14% 8.243% 41.13% 20.522%
Yield Quality
Operating Profit To Total Profits
0.25% 97.954% -0.21% 97.960% -0.1% 97.707% 0.05% 98.170%
Tax To Total Profits
-11.44% 15.294% -1.81% 16.622% 0.46% 17.270% -0.08% 16.929%
Operating Cash To Total Revenue
-96.56% 1.049% 26.99% 19.824% 37.6% 30.455% -26.75% 15.610%
Capital Structure
Debt Assets Ratio
-11.89% 18.633% -22.46% 19.159% -17.78% 21.147% 7.55% 24.707%
Equity Multipler
-3.09% 1.229 -6.86% 1.237 -5.8% 1.2682 2.3% 1.3281
Debt Equity Ratio
-14.61% 22.899% -27.78% 23.700% -22.55% 26.818% 10.03% 32.815%
Current Assets To tatal Assets
-0.24% 75.219% -0.17% 75.302% 1.68% 75.402% -0.08% 75.431%
Non Current Assets To Total Assets
0.74% 24.781% 0.52% 24.698% -4.81% 24.598% 0.25% 24.569%
Current Liabilities To tatal Liabilities
-4.61% 85.621% -3.6% 86.307% 0.61% 89.762% -1.63% 89.531%
Non Current Liabilities To Total Liabilities
40.45% 14.379% 30.8% 13.693% -5.04% 10.238% 16.52% 10.469%
Solvency
Current Ratio
18.7% 4.7149 33.55% 4.554 22.92% 3.9723 -5.56% 3.41
Quick Ratio
12.31% 3.6964 36.16% 3.6907 27.69% 3.2913 -5.96% 2.7106
Operating Profit To Current Liabilities
-24.49% 0.3136 -8.25% 0.8829 -20.01% 0.4153 28.41% 0.9623
Operrating Cash Flow To Current Liabilities
-96.37% 0.0114 11.34% 0.4912 -4.2% 0.3149 -21.24% 0.4412
Share Equity Without Minority Interest To Total Liabilities
17.11% 4.3669 38.46% 4.2195 29.12% 3.7288 -9.12% 3.0474
Operating Cash Flow To Total Liabilities
-96.54% 0.0098 7.33% 0.424 -3.62% 0.2827 -22.52% 0.395
Operating Profit To Total Liabilities
-27.97% 0.2685 -11.55% 0.762 -19.52% 0.3728 26.32% 0.8616
Operating Capacity
Inventory Turnover(T)
-30.82% 0.3593 -21.45% 1.1137 -29.76% 0.5194 -4.74% 1.4178
Current Assets Turnover(T)
-27.09% 0.2344 -25.72% 0.7012 -34.54% 0.3215 25.22% 0.944
Fixed Assets Turnover(T)
-19.61% 1.2358 -19.68% 3.279 -32.93% 1.5372 -6.38% 4.0822
Total Assets Turnover(T)
-27.23% 0.1764 -25.83% 0.5283 -33.98% 0.2424 18.22% 0.7123
Growth Ability
Operating Revenue GR 3Y
-63.94% 64.925% -27.88% 174.727% -32.97% 180.038% 35.21% 242.270%
Gross Income GR 3Y
-65.75% 63.731% -31.04% 167.869% -31.17% 186.083% 38.43% 243.444%
Operating Profit GR 3Y
-75.96% 52.125% -19.26% 192.131% -26.3% 216.803% 90.47% 237.956%
EBT GR 3Y
-76.7% 51.619% -17.3% 197.033% -24.31% 221.575% 98.22% 238.252%
Net Profit GR 3Y
-72.17% 58.222% -20.64% 194.684% -24.95% 209.200% 115.17% 245.312%
Net Profit Attributable To The Parent Company GR 3Y
-72.17% 58.222% -20.64% 194.684% -24.95% 209.200% 115.17% 245.312%
Total Assets GR 3Y
-60.77% 158.568% -27.93% 191.380% -- 404.210% -1.33% 265.532%
Share Equity Without Minority Interest GR 3Y
-61.65% 180.377% -27.48% 202.422% -- 470.303% -21.58% 279.122%
Equity GR 3Y
-61.65% 180.377% -27.48% 202.422% -- 470.303% -21.58% 279.122%
Total Liabilities GR 3Y
-63.1% 93.007% -33.57% 152.480% -- 252.069% 83.26% 229.532%
Basic Earning Per Share GR 3Y
-56.5% 44.578% -38.2% 98.214% -45.89% 102.469% 220.86% 158.929%
Net Assets Per Share GR 3Y
-- 160.835% -- 171.109% -- -- -- --
Other Indicators
Currency Unit
HKDHKDHKDHKD

Q6, Q9, and FY are cumulative quarterly reports: Q6 is the interim report; Q9 is third quarter report; FY is the annual report.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%

Back to the Top